202 related articles for article (PubMed ID: 26610873)
21. Norepinephrine reuptake inhibitors and risk of antihypertensive treatment intensification and major adverse cardiovascular events in patients with stable hypertension and depression.
Desai R; Park H; Brown JD; Mohandas R; Smith SM
Pharmacotherapy; 2022 Jun; 42(6):472-482. PubMed ID: 35478186
[TBL] [Abstract][Full Text] [Related]
22. Diffusion of new generation antidepressant treatment among elderly diagnosed with depression.
Sambamoorthi U; Olfson M; Walkup JT; Crystal S
Med Care; 2003 Jan; 41(1):180-94. PubMed ID: 12544554
[TBL] [Abstract][Full Text] [Related]
23. Fluoxetine versus other types of pharmacotherapy for depression.
Magni LR; Purgato M; Gastaldon C; Papola D; Furukawa TA; Cipriani A; Barbui C
Cochrane Database Syst Rev; 2013 Jul; (7):CD004185. PubMed ID: 24353997
[TBL] [Abstract][Full Text] [Related]
24. Antidepressants and Hepatotoxicity: A Cohort Study among 5 Million Individuals Registered in the French National Health Insurance Database.
Billioti de Gage S; Collin C; Le-Tri T; Pariente A; Bégaud B; Verdoux H; Dray-Spira R; Zureik M
CNS Drugs; 2018 Jul; 32(7):673-684. PubMed ID: 29959758
[TBL] [Abstract][Full Text] [Related]
25. Retrospective analysis of the health-care costs of bupropion sustained release in comparison with other antidepressants.
Poret AW; Neslusan C; Ricci JF; Wang S; Khan ZM; Kwong JW
Value Health; 2001; 4(5):362-9. PubMed ID: 11705126
[TBL] [Abstract][Full Text] [Related]
26. Diagnosing and treating depression in the elderly.
Nelson JC
J Clin Psychiatry; 2001; 62 Suppl 24():18-22. PubMed ID: 11676429
[TBL] [Abstract][Full Text] [Related]
27. Use of antidepressant medications: are there differences in psychiatric visits among patient treatments in the Veterans Administration?
Hamed A; Lee A; Ren XS; Miller DR; Cunningham F; Zhang H; Kazis LE
Med Care; 2004 Jun; 42(6):551-9. PubMed ID: 15167323
[TBL] [Abstract][Full Text] [Related]
28. Antidepressants strongly influence the relationship between depression and heart rate variability: findings from The Irish Longitudinal Study on Ageing (TILDA).
O'Regan C; Kenny RA; Cronin H; Finucane C; Kearney PM
Psychol Med; 2015 Feb; 45(3):623-36. PubMed ID: 25075912
[TBL] [Abstract][Full Text] [Related]
29. Tolerability of concomitant use of selective serotonin reuptake inhibitors or serotonin-norepinephrine reuptake inhibitors and oxymorphone extended release.
Peniston JH; Hu X; Potts SL; Wieman MS; Turk DC
Postgrad Med; 2012 Mar; 124(2):114-22. PubMed ID: 22437221
[TBL] [Abstract][Full Text] [Related]
30. Assessing the comparative-effectiveness of antidepressants commonly prescribed for depression in the US Medicare population.
Kaplan C; Zhang Y
J Ment Health Policy Econ; 2012 Dec; 15(4):171-8. PubMed ID: 23525835
[TBL] [Abstract][Full Text] [Related]
31. Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of migraine in adults.
Banzi R; Cusi C; Randazzo C; Sterzi R; Tedesco D; Moja L
Cochrane Database Syst Rev; 2015 Apr; 4(4):CD002919. PubMed ID: 25829028
[TBL] [Abstract][Full Text] [Related]
32. Functional and cognitive outcomes after suprapubic catheter placement in nursing home residents: A national cohort study.
Chou WH; Covinsky K; Zhao S; Boscardin WJ; Finlayson E; Suskind AM
J Am Geriatr Soc; 2022 Oct; 70(10):2948-2957. PubMed ID: 35696283
[TBL] [Abstract][Full Text] [Related]
33. Efficacy and tolerability of moclobemide in comparison with placebo, tricyclic antidepressants, and selective serotonin reuptake inhibitors in elderly depressed patients: a clinical overview.
Amrein R; Stabl M; Henauer S; Affolter E; Jonkanski I
Can J Psychiatry; 1997 Dec; 42(10):1043-50. PubMed ID: 9469236
[TBL] [Abstract][Full Text] [Related]
34. Selective Serotonin Reuptake Inhibitors and Serotonin and Noradrenaline Reuptake Inhibitors Improve Cognitive Function in Partial Responders Depressed Patients: Results from a Prospective Observational Cohort Study.
Castellano S; Ventimiglia A; Salomone S; Ventimiglia A; De Vivo S; Signorelli MS; Bellelli E; Santagati M; Cantarella RA; Fazio E; Aguglia E; Drago F; Di Nuovo S; Caraci F
CNS Neurol Disord Drug Targets; 2016; 15(10):1290-1298. PubMed ID: 27712575
[TBL] [Abstract][Full Text] [Related]
35. Comparative efficacy and acceptability of antidepressants in Parkinson's disease: a network meta-analysis.
Liu J; Dong J; Wang L; Su Y; Yan P; Sun S
PLoS One; 2013; 8(10):e76651. PubMed ID: 24098546
[TBL] [Abstract][Full Text] [Related]
36. Comparison of agomelatine and selective serotonin reuptake inhibitors/serotonin-norepinephrine reuptake inhibitors in major depressive disorder: A meta-analysis of head-to-head randomized clinical trials.
Huang KL; Lu WC; Wang YY; Hu GC; Lu CH; Lee WY; Hsu CC
Aust N Z J Psychiatry; 2014 Jul; 48(7):663-71. PubMed ID: 24604920
[TBL] [Abstract][Full Text] [Related]
37. Association of Antidepressant Medications With Incident Type 2 Diabetes Among Medicaid-Insured Youths.
Burcu M; Zito JM; Safer DJ; Magder LS; dosReis S; Shaya FT; Rosenthal GL
JAMA Pediatr; 2017 Dec; 171(12):1200-1207. PubMed ID: 29049533
[TBL] [Abstract][Full Text] [Related]
38. The use of antidepressants in Belgian nursing homes: focus on indications and dosages in the PHEBE study.
Bourgeois J; Elseviers MM; Van Bortel L; Petrovic M; Vander Stichele RH
Drugs Aging; 2012 Sep; 29(9):759-69. PubMed ID: 23018612
[TBL] [Abstract][Full Text] [Related]
39. Risk of vaginal bleeding and postpartum hemorrhage after use of antidepressants in pregnancy: a study from the Norwegian Mother and Child Cohort Study.
Lupattelli A; Spigset O; Koren G; Nordeng H
J Clin Psychopharmacol; 2014 Feb; 34(1):143-8. PubMed ID: 24135843
[TBL] [Abstract][Full Text] [Related]
40. SNRIs achieve faster antidepressant effects than SSRIs by elevating the concentrations of dopamine in the forebrain.
Li J; Lu C; Gao Z; Feng Y; Luo H; Lu T; Sun X; Hu J; Luo Y
Neuropharmacology; 2020 Oct; 177():108237. PubMed ID: 32710978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
